Download PDF
1 / Pages

Other users also viewed these articles

Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU) Lluís Masana; José López Miranda; Fernando Civeira; Leonardo Reinares; Carlos Guijarro; Núria Plana; Rafael Cuenca; Demetrio Sánchez; José Luis Hernández; Raimundo Andrés; Agustín Blanco; Santiago Villamayor;
Clin Investig Arterioscler. 2020;32:183-92
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines Pedro Armario; Carlos Brotons; Roberto Elosua; Maria Alonso de Leciñana; Almudena Castro; Albert Clarà; Olga Cortés; Ángel Díaz Rodriguez; María Herranz; Soledad Justo; Carlos Lahoz; Juan Pedro-Botet; Antonio Pérez Pérez; Rafael Santamaria; Ricard Tresserras; Susana Aznar Lain; Miguel Ángel Royo-Bordonada;
Clin Investig Arterioscler. 2021;33:85-107
Dyslipidemia treatment strategies in primary and secondary prevention. Dyslipemia Registry of the Spanish Arteriosclerosis Society Victoria Marco-Benedí; Ana M. Bea; Rosa M. Sánchez Hernández; Núria Plana; Pedro Valdivielso; Fernando Civeira;
Clin Investig Arterioscler. 2022;34:303-10